- Home
- MI vs IMA Comparison
MI vs IMA Comparison
Compare MI & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MI | IMA |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.3M | 65.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MI | IMA |
|---|---|---|
| Price | $4.11 | $7.07 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 7.7K | ★ 52.5K |
| Earning Date | 05-07-2026 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $662,718.00 | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.57 | $5.70 |
| 52 Week High | $4.59 | $18.00 |
Technical Indicators
Market Signals| Indicator | MI | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | N/A |
| Support Level | $3.71 | N/A |
| Resistance Level | $4.59 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 51.52 | 0.00 |
Price Performance
Historical ComparisonAbout MI NFT Limited
NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.